drugset / Trial / NCT04379024
Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms
RandomizedParallel-groupOpen-labelPrevention
Summary
Pilot study to test feasibility of 6 months of Duavee® vs wait-list control in post-menopausal women symptomatic for hot flashes.
Timeline
- Start
- 2020-06-01
- Primary completion
- 2021-07-30
- Completion
- 2021-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bazedoxifene | Other / unclassified | 20 mg | Oral |
| Subject | conjugated estrogens | Other / unclassified | 0.45 mg | Oral |
Indications
No indication recorded.